
TransMedics Group TMDX
$ 99.05
-3.08%
Annual report 2025
added 02-24-2026
TransMedics Group Total Current Liabilities 2011-2026 | TMDX
Annual Total Current Liabilities TransMedics Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89.3 M | 59.9 M | 54.9 M | 23.7 M | 23.2 M | 11.9 M | 16.1 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 89.3 M | 11.9 M | 39.9 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | ||
|
Xtant Medical Holdings
XTNT
|
28.6 M | $ 0.55 | -2.31 % | $ 73.5 M | ||
|
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | ||
|
Zimmer Biomet Holdings
ZBH
|
2.45 B | $ 88.57 | -0.65 % | $ 18 B | ||
|
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | ||
|
Alphatec Holdings
ATEC
|
219 M | $ 10.93 | -5.12 % | $ 1.64 B | ||
|
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | ||
|
Accuray Incorporated
ARAY
|
193 M | $ 0.4 | 4.21 % | $ 41.1 M | ||
|
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
6.6 M | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | ||
|
CONMED Corporation
CNMD
|
315 M | $ 34.58 | -5.62 % | $ 1.07 B | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
2.72 M | - | - | $ 1.08 M | ||
|
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | ||
|
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
9.82 M | $ 0.59 | -1.18 % | $ 32.1 M | ||
|
Aethlon Medical
AEMD
|
1.9 M | $ 2.15 | -5.29 % | $ 3.36 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.81 B | $ 79.34 | -3.36 % | $ 46.4 B | ||
|
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
712 M | $ 11.2 | -1.84 % | $ 1.51 B | ||
|
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 15.52 | -5.08 % | $ 364 M | ||
|
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
7.58 M | - | 10.0 % | $ 610 K | ||
|
Myomo
MYO
|
8.35 M | $ 0.7 | 2.32 % | $ 29.3 M | ||
|
Penumbra
PEN
|
183 M | $ 335.1 | -0.39 % | $ 13 B | ||
|
Inspire Medical Systems
INSP
|
96.1 M | $ 50.13 | -0.63 % | $ 1.47 B | ||
|
Pulmonx Corporation
LUNG
|
20.1 M | $ 1.17 | -5.65 % | $ 47.6 M | ||
|
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
716 M | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
103 M | - | - | $ 217 M | ||
|
Surgalign Holdings
SRGA
|
21.1 M | - | -32.98 % | $ 1.68 M | ||
|
STRATA Skin Sciences
SSKN
|
13.4 M | - | - | $ 6.6 M | ||
|
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | ||
|
AVITA Medical
RCEL
|
62.7 M | $ 3.82 | -1.04 % | $ 106 M | ||
|
AxoGen
AXGN
|
23.6 M | $ 31.28 | -3.01 % | $ 1.44 B | ||
|
Delcath Systems
DCTH
|
11 M | $ 8.97 | -1.75 % | $ 321 M |